{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:48:22Z","timestamp":1775890102999,"version":"3.50.1"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Although it is well-established that children undergoing allogeneic stem cell transplants and treatment for leukemia should be offered prophylaxis against <jats:italic toggle=\"yes\">Pneumocystis jirovecii<\/jats:italic> pneumonia, the risk for children with solid malignancies is less certain. This guideline has been developed with the aim of standardizing practice and optimizing the benefit versus risk of prophylactic medication in this group of patients. <jats:italic toggle=\"yes\">P. jirovecii<\/jats:italic> pneumonia has a high mortality rate even with prompt antimicrobial treatment. Since prophylaxis with co-trimoxazole is safe, effective, and inexpensive, we suggest that all children with malignancies undergoing immunosuppressive therapy are offered prophylaxis unless there are clear contraindications.<\/jats:p>","DOI":"10.1097\/mph.0000000000000771","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T15:08:08Z","timestamp":1488899288000},"page":"194-202","source":"Crossref","is-referenced-by-count":25,"title":["Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors"],"prefix":"10.1097","volume":"39","author":[{"given":"Rebecca","family":"Proudfoot","sequence":"first","affiliation":[{"name":"Department of Paediatrics, John Radcliffe Hospital, Oxford"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Phillips","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination, University of York, York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Wilne","sequence":"additional","affiliation":[{"name":"Paediatric Oncology Department, University Hospitals Nottingham NHS Trust, Queen\u2019s Medical Centre, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/334519a0","article-title":"Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi","volume":"334","author":"Edman","year":"1988","journal-title":"Nature"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/319340","article-title":"Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants","volume":"32","author":"Vargas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.61.1.35","article-title":"Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children","volume":"61","author":"Pifer","year":"1978","journal-title":"Pediatrics"},{"issue":"pt 1","key":"R4-20230918","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1542\/peds.19.4.543","article-title":"Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants","volume":"19","author":"Gajdusek","year":"1957","journal-title":"Pediatrics"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM198112103052401","article-title":"Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency","volume":"305","author":"Gottlieb","year":"1981","journal-title":"N Engl J Med"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM198112103052402","article-title":"An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction","volume":"305","author":"Masur","year":"1981","journal-title":"N Engl J Med"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"316","author":"Hughes","year":"1987","journal-title":"N Engl J Med"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.qai.0000171727.55553.78","article-title":"Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states","volume":"40","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archinte.1995.00430110015002","article-title":"Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk","volume":"155","author":"Sepkowitz","year":"1995","journal-title":"Arch Intern Med"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"297","author":"Hughes","year":"1977","journal-title":"N Engl J Med"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.2820360912","article-title":"Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis","volume":"36","author":"Hughes","year":"1975","journal-title":"Cancer"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1542\/peds.2006-1360","article-title":"Successful intermittent prophylaxis with trimethoprim\/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients","volume":"120","author":"Lindemulder","year":"2007","journal-title":"Pediatrics"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pbc.21774","article-title":"Intermittent oral trimethoprim\/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation","volume":"52","author":"Ohata","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","article-title":"Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (D","volume":"92","author":"Neumann","year":"2013","journal-title":"Ann Hematol"},{"key":"R18-20230918","year":"2013"},{"key":"R19-20230918","first-page":"CD005590","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"3","author":"Green","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/adc.2009.161570","article-title":"\u201cThere is nothing like looking, if you want to find something\u201d\u2014asking questions and searching for answers\u2014the evidence based approach","volume":"95","author":"Haroon","year":"2010","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"jul31_1","key":"R22-20230918","doi-asserted-by":"crossref","first-page":"a744","DOI":"10.1136\/bmj.a744","article-title":"Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive","volume":"337","author":"Jaeschke","year":"2008","journal-title":"BMJ"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Qualitative research: consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"suppl 2","key":"R25-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00944_1.x","article-title":"British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011","volume":"12","author":"Nelson","year":"2011","journal-title":"HIV Med"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clml.2011.07.006","article-title":"Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders","volume":"12","author":"Obeid","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00365540601150497","article-title":"Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004","volume":"39","author":"Overgaard","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.idc.2009.10.010","article-title":"Pneumocystis jirovecii pneumonia","volume":"24","author":"Catherinot","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3476(73)80113-1","article-title":"Pneumocystis carinii pneumonitis in children with malignancies","volume":"82","author":"Hughes","year":"1973","journal-title":"J Pediatr"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","article-title":"Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital","volume":"267","author":"Sepkowitz","year":"1992","journal-title":"JAMA"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.1970.03180060052010","article-title":"Pneumocystis carinii pneumonia in a hospital for children. Epidemiologic aspects","volume":"214","author":"Perera","year":"1970","journal-title":"JAMA"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archpedi.1980.02130190011004","article-title":"Chemoprophylaxis for Pneumocystis carinii pneumonitis. Outcome of unstructured delivery","volume":"134","author":"Wilber","year":"1980","journal-title":"Am J Dis Child"},{"key":"R35-20230918","first-page":"337","article-title":"Pneumocystis carinii infection in children with acute leukemia and non-Hodgkin malignant lymphoma","volume":"58","author":"Cyklis","year":"1983","journal-title":"Pediatr Pol"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/archneur.1991.00530160074017","article-title":"Pneumocystis carinii pneumonia in patients with primary brain tumors","volume":"48","author":"Henson","year":"1991","journal-title":"Arch Neurol"},{"issue":"suppl 2","key":"R37-20230918","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","article-title":"Pneumocystis carinii pneumonia in patients without AIDS","volume":"17","author":"Sepkowitz","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6602412","article-title":"An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital","volume":"92","author":"Worth","year":"2005","journal-title":"Br J Cancer"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","article-title":"Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (D","volume":"92","author":"Neumann","year":"2013","journal-title":"Ann Hematol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.12.085","article-title":"Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection","volume":"62","author":"Hughes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0305-7372(03)00002-1","article-title":"Pneumocystis carinii pneumonia prophylaxis in HIV negative patients with primary CNS lymphoma","volume":"29","author":"Mathew","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-0774","article-title":"Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide","volume":"17","author":"Grossman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpedi.1980.02130130027008","article-title":"Prevention of pneumocystis pneumonia. Use of continuous sulfamethoxazole-trimethroprim therapy","volume":"134","author":"Harris","year":"1980","journal-title":"Am J Dis Child (1911)"},{"key":"R45-20230918"},{"key":"R46-20230918","first-page":"47","article-title":"Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole","volume":"112","author":"Hughes","year":"1975","journal-title":"Can Med Assoc J"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/INF.0b013e318292f560","article-title":"Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation","volume":"32","author":"DeMasi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pbc.21287","article-title":"Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients","volume":"50","author":"Kim","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.1994.12.2.258","article-title":"Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim\/sulfamethoxazole","volume":"12","author":"Mustafa","year":"1994","journal-title":"J Clin Oncol"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/INF.0000000000000044","article-title":"Efficacy and tolerability of intravenous pentamidine isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology population","volume":"33","author":"Orgel","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"S16","key":"R51-20230918","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ppul.19502308105","article-title":"Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection","volume":"23","author":"Gupta","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/pbc.21202","article-title":"Pneumocystis pneumonia in children receiving chemotherapy","volume":"50","author":"Prasad","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/cncr.25904","article-title":"Dapsone-induced methemoglobinemia: a dose-related occurrence?","volume":"117","author":"Esbenshade","year":"2011","journal-title":"Cancer"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1702004","article-title":"A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim\/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation","volume":"24","author":"Colby","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0022-3476(05)83351-7","article-title":"Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia","volume":"117","author":"Ferrazzini","year":"1990","journal-title":"J Pediatr"},{"key":"R56-20230918","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.1994.12.8.1667","article-title":"Patient characteristics associated with high-risk methotrexate concentrations and toxicity","volume":"12","author":"Relling","year":"1994","journal-title":"J Clin Oncol"},{"key":"R57-20230918","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12253-008-9073-5","article-title":"Late immune recovery in children treated for malignant diseases","volume":"14","author":"Kovacs","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00043426-199809000-00008","article-title":"Immune recovery in children with malignancy after cessation of chemotherapy","volume":"20","author":"Mustafa","journal-title":"J Pediatr Hematol Oncol"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/bmt.2010.285","article-title":"Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal","volume":"46","author":"Fontanet","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R60-20230918","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"R61-20230918","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/clinids\/24.Supplement_1.S63","article-title":"Increases in rates of resistance to trimethoprim","volume":"24","author":"Huovinen","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R62-20230918","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1086\/315132","article-title":"Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era","volume":"180","author":"Martin","year":"1999","journal-title":"J Infect Dis"},{"key":"R63-20230918","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(90)90337-D","article-title":"A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophy","volume":"89","author":"Fox","year":"1990","journal-title":"Am J Med"},{"key":"R64-20230918","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1128\/AAC.01161-13","article-title":"Trimethoprim resistance of dihydrofolate reductase (DHFR) variants from clinical isolates of Pneumocystis jirovecii","volume":"57","author":"Queener","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R65-20230918","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1128\/AAC.48.11.4301-4305.2004","article-title":"Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis","volume":"48","author":"Nahimana","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R67-20230918","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/pbc.24665","article-title":"Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors","volume":"60","author":"Brown","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R68-20230918","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9343(87)90380-9","article-title":"Pneumocystis carinii pneumonia. Review of 53 cases","volume":"82","author":"Peters","year":"1987","journal-title":"Am J Med"},{"key":"R69-20230918","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/1097-0142(197203)29:3<772::AID-CNCR2820290333>3.0.CO;2-K","article-title":"Pneumocystis carinii in children with malignant disease","volume":"29","author":"Sedaghatian","year":"1972","journal-title":"Cancer"},{"key":"R70-20230918","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1016\/j.bbmt.2011.12.300","article-title":"Safety and efficacy of intravenous pentamidine in children and adolescents undergoing hematopoietic stem cell transplantation","volume":"2","author":"DeMasi","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R71-20230918","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/cncr.22562","article-title":"Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia","volume":"109","author":"Madden","year":"2007","journal-title":"Cancer"},{"key":"R72-20230918","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R73-20230918","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R74-20230918","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201704000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:04:25Z","timestamp":1695013465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201704000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000771","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}